Our Firm represents various Pharmaceutical Companies on advisory work on DPCO and NPPA related matters and regulatory compliances including litigation related thereto. The firm has a pharma regulatory practice that is actively involved in all developments in the pharma regulatory space and represents and advises clients in relation challenging the constitutional validity of the provisions of the Drugs (Price Control) Order, 2013, challenging FDC notifications, Price Ceiling Notifications, Price Fixation of Scheduled Drugs as notified by the National Pharmaceutical Pricing Authority.
The Firm has a fairly diverse practice in the field of Biodiversity laws and the prevalent provisions of the same in India and our team has experience and expertise in opining and suggesting a way forward on the access benefit sharing. We have also assisted our client with respect to replying to the notices issued by various biodiversity boards and we have been involved in assisting in seeking permission for usage of biological resources, providing advisory and consultancy to various pharma companies and manufacturers on various aspects relating to claims against companies/ manufacturers and handling cases on their behalf.